NCT03855514View on ClinicalTrials.gov

Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

December 30, 2021

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

NuShield

NuShield® is a dehydrated placental allograft.

Trial Locations (9)

11501

RECRUITING

NYU Winthrop Hospital, New York

30076

RECRUITING

Extremity Healthcare, Roswell

33143

RECRUITING

Doctors Research Network, Miami

78501

RECRUITING

Futuro Clinical Trials, McAllen

91208

RECRUITING

University of Southern California, Los Angeles

92002

RECRUITING

ILD Research Center, Carlsbad

94063

RECRUITING

Limb Preservation Platform, Fresno

RECRUITING

Stanford University, Redwood City

06606

RECRUITING

Family Foot & Ankle Specialists, Bridgeport

Sponsors

Lead Sponsor

Organogenesis
All Listed Sponsors
lead

Organogenesis

INDUSTRY

NCT03855514 - Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter